Episode Details

This episode explores the strategic pathway for medical device market entry into Brazil, the largest MedTech market in Latin America. We analyze the case of Zimmer Biomet Brasil Ltda. to illustrate the critical importance of establishing a local subsidiary, securing a Brazil Registration Holder (BRH), and navigating the complex regulatory landscape governed by ANVISA, including requirements like Brazilian Good Manufacturing Practice (BGMP) and INMETRO certification. - What makes Brazil an attractive yet challenging market for device manufacturers? - Why can't foreign companies directly register devices with Brazil's ANVISA? - What is a Brazil Registration Holder (BRH) and why is it essential? - How does a company's corporate structure, like its CNAE code, impact operations in Brazil? - What are the key steps in the ANVISA registration process? - Are on-site inspections for Brazilian Good Manufacturing Practice (BGMP) always required? - When is an INMETRO certification necessary for medical devices? - How did Zimmer Biomet structure its Brazilian subsidiary for success? Pure Global offers end-to-end regulatory consulting solutions for MedTech and IVD companies, combining local expertise with advanced AI to streamline global market access. We act as your local representative in over 30 markets, developing efficient pathways for regulatory approval. Our AI-powered tools help compile and submit technical dossiers, while our team provides continuous monitoring of regulatory changes. For startups to multinational enterprises, we provide scalable solutions. Learn more about accessing markets like Brazil faster at https://pureglobal.com/, contact us at info@pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.